Annual report
4272.TEDINET S100YD4R
Period2025-04-01 → 2026-03-31
Filed2026-06-19
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 152
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥241.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥222.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥201.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥198.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥184.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥22.5bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥20.4bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥25.5bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥22.3bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥12.6bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.0bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.2bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥33.6bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥22.0bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥24.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.1bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥15.0bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥17.2bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥24.7bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥17.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥398.7bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥373.7bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥363.2bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥322.9bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥315.5bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥118.6bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥105.2bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥280.1bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥268.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥270.5bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥255.0bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥246.4bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥50.0bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥55.4bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥53.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥57.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.1bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥53.0bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥28.8bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥25.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.2bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥20.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥23.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥17.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥27.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.4bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15.2bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.6bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥20.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥11.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥161.18 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥107.17 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.8 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.36 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.7 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥161.18 | 2025-04-01 → 2026-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥107.16 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.79 | 2023-04-01 → 2024-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.33 | 2022-04-01 → 2023-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.65 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,878.87 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,673.24 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,625.18 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,532.35 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,459.06 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 70.0% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.8% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.0% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 1.6% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 5,946 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 5,979 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 5,902 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 5,782 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 5,703 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥145.1bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥130.5bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥120.5bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥128.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥124.0bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥9.2bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥4.5bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥28.8bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥13.0bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.6bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥17.2bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.1bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥36.9bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥12.8bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥30.8bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥11.4bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥666m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥12.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥12.6bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥280.7bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥265.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥261.6bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥237.5bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥236.4bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥100.6bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥88.1bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥180.0bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥177.3bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥185.2bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥185.2bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥184.8bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥15.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥16.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥201.69 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.65 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.02 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.33 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.63 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥66 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,212.36 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,109.15 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,116.51 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,117.38 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,098.36 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 64.1% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.8% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.0% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.2% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 17.3% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 160,000,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 165,003,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 170,503,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 170,503,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 170,503,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,366 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 2,423 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 2,419 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 2,391 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 2,398 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 87
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥402m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥588m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥138m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥138m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥53.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥9.8bn |
| Fine Chemicals Business Unitreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥6.2bn |
| Fine Chemicals Business Unitreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥5.0bn |
| Fine Chemicals Business Unitreportable segment | employees | at 2026-03-31 | 1383 pure |
| Fine Chemicals Business Unitreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥74.2bn |
| Fine Chemicals Business Unitreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥74.1bn |
| Fine Chemicals Business Unitreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥84m |
| Fine Chemicals Business Unitreportable segment | segment assets | at 2026-03-31 | ¥97.0bn |
| Fine Chemicals Business Unitreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥11.9bn |
| Life Science Business Unitreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥5.8bn |
| Life Science Business Unitreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥2.9bn |
| Life Science Business Unitreportable segment | employees | at 2026-03-31 | 943 pure |
| Life Science Business Unitreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥73.0bn |
| Life Science Business Unitreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥73.0bn |
| Life Science Business Unitreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥0 |
| Life Science Business Unitreportable segment | segment assets | at 2026-03-31 | ¥104.1bn |
| Life Science Business Unitreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥9.7bn |
| Mobility And Imaging Business Unitreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥8.1bn |
| Mobility And Imaging Business Unitreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥7.1bn |
| Mobility And Imaging Business Unitreportable segment | employees | at 2026-03-31 | 3360 pure |
| Mobility And Imaging Business Unitreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥94.8bn |
| Mobility And Imaging Business Unitreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥94.7bn |
| Mobility And Imaging Business Unitreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥53m |
| Mobility And Imaging Business Unitreportable segment | segment assets | at 2026-03-31 | ¥144.2bn |
| Mobility And Imaging Business Unitreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥10.7bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥20.1bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥15.0bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥242.0bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥241.9bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥138m |
| —segment total | segment assets | at 2026-03-31 | ¥345.3bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥32.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥20.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥15.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥242.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥241.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥138m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥345.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥32.3bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥593m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥196m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥196m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥61.7bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥9.2bn |
| Fine Chemicals Business Unitreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥12.6bn |
| Fine Chemicals Business Unitreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥3.8bn |
| Fine Chemicals Business Unitreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥66.4bn |
| Fine Chemicals Business Unitreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥66.2bn |
| Fine Chemicals Business Unitreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥196m |
| Fine Chemicals Business Unitreportable segment | segment assets | at 2025-03-31 | ¥94.5bn |
| Fine Chemicals Business Unitreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥9.9bn |
| Life Science Business Unitreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥4.8bn |
| Life Science Business Unitreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| Life Science Business Unitreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥65.0bn |
| Life Science Business Unitreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥65.0bn |
| Life Science Business Unitreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥0 |
| Life Science Business Unitreportable segment | segment assets | at 2025-03-31 | ¥86.7bn |
| Life Science Business Unitreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥6.4bn |
| Mobility And Imaging Business Unitreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥9.0bn |
| Mobility And Imaging Business Unitreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥6.7bn |
| Mobility And Imaging Business Unitreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥91.4bn |
| Mobility And Imaging Business Unitreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥91.4bn |
| Mobility And Imaging Business Unitreportable segment | segment assets | at 2025-03-31 | ¥130.8bn |
| Mobility And Imaging Business Unitreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥13.3bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥26.5bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥13.3bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥222.8bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥222.6bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥196m |
| —segment total | segment assets | at 2025-03-31 | ¥312.0bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥29.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥222.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥222.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥196m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥312.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥29.6bn |
| Fine Chemicals Business Unitreportable segment | employees | at 2026-03-31 | 696 pure |
| Life Science Business Unitreportable segment | employees | at 2026-03-31 | 889 pure |
| Mobility And Imaging Business Unitreportable segment | employees | at 2026-03-31 | 521 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,193
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest expenses ope cf | Prior1YearDuration | 224000000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 472000000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YearDuration | -174000000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYearDuration | -1403000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YearDuration | -61000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYearDuration | 42000000 | JPY |
| Gain on sales of property plant and equipment ope cf | Prior1YearDuration | -9000000 | JPY |
| Gain on sales of property plant and equipment ope cf | CurrentYearDuration | -109000000 | JPY |
| Loss gain on disposal of property plant and equipment ope cf | Prior1YearDuration | 1176000000 | JPY |
| Loss gain on disposal of property plant and equipment ope cf | CurrentYearDuration | 828000000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YearDuration | 2605000000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYearDuration | 284000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YearDuration | -3849000000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYearDuration | -9431000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | -2884000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | -2655000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | -4978000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | -9630000000 | JPY |
| Decrease increase in prepaid expenses ope cf | Prior1YearDuration | 265000000 | JPY |
| Decrease increase in prepaid expenses ope cf | CurrentYearDuration | 194000000 | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YearDuration | -2265000000 | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYearDuration | 932000000 | JPY |
| Decrease increase in advance payments ope cf | Prior1YearDuration | -1295000000 | JPY |
| Decrease increase in advance payments ope cf | CurrentYearDuration | -123000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | 961000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | 3271000000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YearDuration | 1749000000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYearDuration | 1244000000 | JPY |
| Increase decrease in accrued expenses ope cf | Prior1YearDuration | 927000000 | JPY |
| Increase decrease in accrued expenses ope cf | CurrentYearDuration | -100000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YearDuration | 12000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYearDuration | -141000000 | JPY |
| Increase decrease in net defined benefit asset ope cf | Prior1YearDuration | -609000000 | JPY |
| Increase decrease in net defined benefit asset ope cf | CurrentYearDuration | -609000000 | JPY |
| Other net ope cf | Prior1YearDuration | 2373000000 | JPY |
| Other net ope cf | CurrentYearDuration | 1795000000 | JPY |
| Subtotal ope cf | Prior1YearDuration | 28449000000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 32263000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration | 2203000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 1658000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration | -192000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -466000000 | JPY |
| Income taxes paid ope cf | Prior1YearDuration | -5401000000 | JPY |
| Income taxes paid ope cf | CurrentYearDuration | -5085000000 | JPY |
| Income taxes refund ope cf | Prior1YearDuration | 471000000 | JPY |
| Income taxes refund ope cf | CurrentYearDuration | 415000000 | JPY |
| Net cash provided by used in operating activities | Prior1YearDuration | 25530000000 | JPY |
| Net cash provided by used in operating activities | CurrentYearDuration | 28784000000 | JPY |
| Payments into time deposits inv cf | Prior1YearDuration | -371000000 | JPY |
| Payments into time deposits inv cf | CurrentYearDuration | -1269000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |